|Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of acute, life-threatening conditions in which a combination of coagulation, inflammation and tissue damage are involved. The company also performs business development activities to identify future collaboration partners and licensing partners. The company’s lead candidate Apta-1 is being developed as an emergency medicine intended to prevent the onset of life-threatening organ and tissue damage in sepsis patients.
|Chairman of the Board
|Bert Junno, Theresa Comiskey Olsen, Johan Lindh, Cristina Glad, Åsa Kornfeld, Jan Nilsson
|Articles of Association
|Articles of Association 2023-06-07. See link below to download (in Swedish)
|Norra Vallgatan 58
|0766-02 01 99
Download the Articles of Association as pdf (in Swedish)